Brief: NextCell Updates On Timing Of ProTrans-Young Results
Mon 09:57
BRIEF-NextCell Updates On Timing Of ProTrans-Young Results Oct 19 (Reuters) - NextCell Pharma AB NXTCL.ST:
PROTRANS-YOUNG CLINICAL TRIAL HAVE NOT YET BEEN REPORTED TO COMPANY
EXTENDED TIMELINE IS DUE TO FINAL ADMINISTRATIVE PROCESSING AND SIGN-OFF OF STUDY DATA TAKING LONGER THAN PLANNED
Source text: ID:nWkr78z35K
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Updates On Timing Of ProTrans-Young Results
Brief: Nextcell Pharma Q2 2026 Operating Income SEK 3.0 Mln
Brief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation